These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 27989797

  • 1. Vitamin D receptor agonist VS-105 directly modulates parathyroid hormone expression in human parathyroid cells and in 5/6 nephrectomized rats.
    Sawada K, Wu-Wong JR, Chen YW, Wessale JL, Kanai G, Kakuta T, Fukagawa M.
    J Steroid Biochem Mol Biol; 2017 Mar; 167():48-54. PubMed ID: 27989797
    [Abstract] [Full Text] [Related]

  • 2. Cardiac effect of vitamin D receptor modulators in uremic rats.
    Mizobuchi M, Ogata H, Yamazaki-Nakazawa A, Hosaka N, Kondo F, Koiwa F, Kinugasa E, Shibata T.
    J Steroid Biochem Mol Biol; 2016 Oct; 163():20-7. PubMed ID: 27072785
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis of VS-105: A novel and potent vitamin D receptor agonist with reduced hypercalcemic effects.
    Chen B, Kawai M, Wu-Wong JR.
    Bioorg Med Chem Lett; 2013 Nov 01; 23(21):5949-52. PubMed ID: 24035340
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the effects of novel vitamin D receptor analog VS-105 and paricalcitol on chronic kidney disease-mineral bone disorder in an experimental model of chronic kidney disease.
    Fujii H, Yonekura Y, Nakai K, Kono K, Goto S, Nishi S.
    J Steroid Biochem Mol Biol; 2017 Mar 01; 167():55-60. PubMed ID: 27818277
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats.
    Noonan W, Koch K, Nakane M, Ma J, Dixon D, Bolin A, Reinhart G.
    Nephrol Dial Transplant; 2008 Dec 01; 23(12):3824-30. PubMed ID: 18644798
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation.
    Lewin E, Garfia B, Recio FL, Rodriguez M, Olgaard K.
    J Am Soc Nephrol; 2002 Aug 01; 13(8):2110-6. PubMed ID: 12138143
    [Abstract] [Full Text] [Related]

  • 10. Direct upregulation of parathyroid calcium-sensing receptor and vitamin D receptor by calcimimetics in uremic rats.
    Mendoza FJ, Lopez I, Canalejo R, Almaden Y, Martin D, Aguilera-Tejero E, Rodriguez M.
    Am J Physiol Renal Physiol; 2009 Mar 01; 296(3):F605-13. PubMed ID: 19091789
    [Abstract] [Full Text] [Related]

  • 11. Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats.
    Slatopolsky E, Finch J, Ritter C, Takahashi F.
    Am J Kidney Dis; 1998 Oct 01; 32(2 Suppl 2):S40-7. PubMed ID: 9808142
    [Abstract] [Full Text] [Related]

  • 12. Vitamin D receptor activator selectivity in the treatment of secondary hyperparathyroidism: understanding the differences among therapies.
    Brancaccio D, Bommer J, Coyne D.
    Drugs; 2007 Oct 01; 67(14):1981-98. PubMed ID: 17883283
    [Abstract] [Full Text] [Related]

  • 13. Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism.
    Cozzolino M, Brancaccio D.
    Expert Opin Pharmacother; 2008 Apr 01; 9(6):947-54. PubMed ID: 18377338
    [Abstract] [Full Text] [Related]

  • 14. Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients.
    Mao J, Wang M, Ni L, Gong W, Jiang X, Zhang Q, Zhang M, Wen D, Chen J.
    Endocrinology; 2021 Jul 01; 162(7):. PubMed ID: 33912936
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
    Brown AJ, Zhong M, Finch J, Ritter C, Slatopolsky E.
    Endocrinology; 1995 Apr 01; 136(4):1419-25. PubMed ID: 7895652
    [Abstract] [Full Text] [Related]

  • 17. Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats.
    Shiizaki K, Negi S, Hatamura I, Sakaguchi T, Saji F, Kunimoto K, Mizobuchi M, Imazeki I, Ooshima A, Akizawa T.
    J Am Soc Nephrol; 2005 Jan 01; 16(1):97-108. PubMed ID: 15574509
    [Abstract] [Full Text] [Related]

  • 18. Comparison of paricalcitol with maxacalcitol injection in Japanese hemodialysis patients with secondary hyperparathyroidism.
    Akizawa T, Akiba T, Hirakata H, Kinugasa E, Tominaga Y, Fukagawa M, Yokoyama K, Zhang W, Linde PG, Suzuki M.
    Ther Apher Dial; 2015 Jun 01; 19(3):225-34. PubMed ID: 25363733
    [Abstract] [Full Text] [Related]

  • 19. Regulation of intestinal vitamin D receptor expression in experimental uraemia: effects of parathyroidectomy and administration of PTH.
    Szabó A, Schmutz A, Pesian S, Schmidt-Gayk H, Ritz E, Reichel H.
    Nephrol Dial Transplant; 1998 Feb 01; 13(2):340-9. PubMed ID: 9509444
    [Abstract] [Full Text] [Related]

  • 20. Mapping the time-dependent effects of paricalcitol on serum calcium, phosphorus and parathyroid hormone levels in 5/6 nephrectomized uremic rats.
    Wu-Wong JR, Nakane M, Chen YW.
    Life Sci; 2013 Feb 07; 92(2):161-6. PubMed ID: 23261531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.